Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026)
Sera Prognostics' (SERA) quarterly Cash & Equivalents came in at $4.2 million in Q1 2026, down 20.17% YoY from $5.2 million in Q1 2025, and up 5.86% on a QoQ basis from $3.9 million in Q4 2025.
Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Cash & Equivalents data on file, last reported at $4.2 million in Q1 2026.
- Quarterly Cash & Equivalents fell 20.17% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 20.17% YoY) and the FY2025 annual result came in at $3.9 million, down 2.45% from the prior year.
- Cash & Equivalents grew to $4.2 million in Q1 2026, from $3.9 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $64.1 million in Q1 2022 to a low of $2.7 million in Q3 2024.
- A 5-year average of $17.5 million and a median of $5.0 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 87.01% — and 2025, when it jumped 52.05%.
- Tracing SERA's Cash & Equivalents over 5 years: stood at $29.9 million in 2022, then tumbled by 87.01% to $3.9 million in 2023, then gained by 4.2% to $4.0 million in 2024, then retreated by 2.45% to $3.9 million in 2025, then gained by 5.86% to $4.2 million in 2026.
- The last three Cash & Equivalents figures came in at $4.2 million (Q1 2026), $3.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | 4.18 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 9.66 Mn |
| Jun 30, 2023 | 32.29 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 29.88 Mn |
| Sep 30, 2022 | 38.81 Mn |
| Jun 30, 2022 | 53.89 Mn |
| Mar 31, 2022 | 64.10 Mn |
| Dec 31, 2021 | 58.93 Mn |
| Sep 30, 2021 | 82.50 Mn |